Tweet Archive for March 2016 « page 5
RT @cebmblog: Why institutions should audit their trial publication record – CEBM cebm.net/institutions-a…
RT @COMPare_Trials: Lessons in Outcome Switching from COMPare: The first blog in the series from @NotDrDalePhD, on the ERASE trial.
https:…
Selective outcome reporting #skincancer. No benefit for patients w/ melanoma undergoing sentinel lymph node biopsy
This is an absolutely damning example of selective outcome reporting in NEJM https://t.co/bWD6zqRQDR
— ben goldacre, MBE LOL (@bengoldacre) March 23, 2016
RT @CebmOxford: Outcome switching, a good example of how science can go wrong. Read about @COMPare_Trials from CEBM @TheEconomist https://t…
New Dermatoscope App To Improve Melanoma Diagnosis #skincancer
iMA Rewind: Heine Releases New Dermatoscope App To Improve Melanoma Diagnosis https://t.co/zOmN7n4GKZ
— iMedicalApps.com (@iMedicalApps) March 26, 2016
Fabulous Liz. How to transform #CompulsiveSkinPicking into a piece of Art! #CompulsiveCharcoal #skin
Hi @ducrest please RT this little film? My free art for London commuters #CompulsiveCharcoal https://t.co/zSL5Cm3SlG pic.twitter.com/S7dJJjJrRX
— Liz Atkin (@LizAtkin) March 26, 2016
Five-Year Safety and Satisfaction Study of PMMA-Collagen in the Correction of Nasolabial Folds. ncbi.nlm.nih.gov/pubmed/2661845… #cosmeticdermatology
Hyaluronidase Caveats for #dermalFillers Complications ncbi.nlm.nih.gov/pubmed/2661846… the article @Dr_Ascher mentioned during @imcasacademy webinar
Scientific journals are retracting more papers than ever before. This is probably good for science voa @voxdotcom vox.com/2016/3/24/1129…
RT @beapen: #peelscore – Dermatologists Sans Borders gulfdoctor.net/s/in #dermatology